Mirtazapine for Methamphetamine Use Disorder: A Randomized Clinical Trial - PubMed
17 hours ago
- #Clinical Trial
- #Mirtazapine
- #Methamphetamine Use Disorder
- Mirtazapine was tested for methamphetamine use disorder in a randomized clinical trial.
- Participants taking mirtazapine had a greater reduction in days of methamphetamine use compared to placebo.
- More adverse events, like drowsiness and weight gain, were reported with mirtazapine.
- No significant effects were found on secondary outcomes like depression or quality of life.
- The study concluded mirtazapine reduced methamphetamine use with no unexpected safety concerns.